Abstract
Since the arthritis drugs Celebrex and Vioxx hit the market 3 years ago, patients and many physicians alike have been under the impression that, unlike traditional arthritis medications, they decrease pain without raising the risk for upper gastrointestinal ulceration and bleeding.
The full text of this article is not available online. Order this issue »